Descartes’ Study Finds 67% of Freight Forwarders and Customs Brokers View Technology as Fundamental to Growth 
From Hong Kong Airport to Hengqin: Chimelong Ferry Sets Sail for a Worry-Free Journey Albireo Presented Data in Cholestatic Liver Diseases at Digestive Disease Week (DDW) 2022
– Six abstracts presented highlighting data on BylvayTM(odevixibat) and effects on pruritus, serum bile acids,…
Day One Announces First Patients Dosed in Phase 1b/2 Combination Study with Tovorafenib (DAY101) and Pimasertib in RAF-altered Solid Tumors
Phase 1b/2 combination study, FIRELIGHT-1, to leverage insights from pediatric development to evaluate potential synergistic…
Innoviva to Acquire Entasis Therapeutics
Innoviva to acquire all outstanding shares of Entasis it does not already own for $2.20…
Quoin Pharmaceuticals Enters Exclusive Research Agreement for Scleroderma Treatment with Australian University
Quoin obtains option to exclusive global rights to product; no upfront or milestone fees ASHBURN,…
Umoja Biopharma and Lupagen Announce New Collaboration to Improve Patient Experience and Access to Next-Generation In Vivo Therapeutics for Cancer
The partnership will evaluate Lupagen’s extracorporeal in vivo delivery technology as a potential additional route…
IO Biotech to Participate in the Jefferies Healthcare Conference
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
CymaBay Therapeutics Presents New Findings that Seladelpar Treatment of PBC Patients for Two Years Predicts Improved Transplant-Free Survival
NEWARK, Calif., May 23, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical…
RAPT Therapeutics Announces Initiation of Phase 2b Trial of RPT193 in Patients with Moderate-to-Severe Atopic Dermatitis
SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
Positive Results from VISEN’s Phase 3 Trial of Once-Weekly TransCon hGH in China Consistent with Ascendis Pharma’s Phase 3 Height Trial
– VISEN’s Phase 3 Trial achieved primary endpoint; pediatric growth hormone deficiency (GHD) patients treated…
Ascendis Pharma A/S Announces New Commercial Endocrinology Leadership Appointments
– Joe Kelly has been appointed to the newly created role of Head of U.S….
Recce Pharmaceuticals Announces Positive Safety Data from Fifth Cohort of Phase I Clinical Trial of RECCE® 327 and Initiates Sixth Cohort at 4,000mg
Highlights: In cohort five, RECCE® 327 (R327) demonstrated good safety and tolerability in subjects intravenously…
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
Former Worldwide Head of Licensing and Acquisition and Knowledge Management at Merck & Co., where…
Ocugen, Inc. to Present at H.C. Wainwright Global Investment Conference
MALVERN, Pa., May 23, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company…
Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma’s Depression Medicines
Fremont, CA, May 23, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC), a…
HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022
MIRAMAR, Fla., May 23, 2022 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB),…
Shockwave Medical and Genesis MedTech Obtain Regulatory Approval in China for Intravascular Lithotripsy
Approvals Cover Both Coronary and Peripheral IVL Catheters and Generators Manufactured by Shockwave SANTA CLARA,…
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., May 23, 2022 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX:…
GitLab 15 Provides Replacement for Do-It-Yourself DevOps with The One DevOps Platform
Latest Iteration Expands Comprehensive DevOps Platform to Drive Digital Innovation SAN FRANCISCO, May 23, 2022…
Manhattan Associates Unveils its New Environmental, Social and Governance (ESG) Website
Educating the market on how supply chain and omnichannel commerce innovations positively affect sustainability, social…
LBank Exchange Will List ANC (ANCT) on May 23, 2022
Internet City, Dubai–(Newsfile Corp. – May 23, 2022) – LBank Exchange, a global digital asset…